Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).

Source:http://linkedlifedata.com/resource/pubmed/id/15251464

FEBS Lett. 2004 Jul 16 570 1-3 195-204

Download in:

View as

General Info

PMID
15251464